Engineered Bacterial Bioreactor for Tumor Therapy via Fenton‐Like Reaction with Localized H2O2 Generation

Synthetic biology based on bacteria has been displayed in antitumor therapy and shown good performance. In this study, an engineered bacterium Escherichia coli MG1655 is designed with NDH‐2 enzyme (respiratory chain enzyme II) overexpression (Ec‐pE), which can colonize in tumor regions and increase...

Full description

Saved in:
Bibliographic Details
Published inAdvanced materials (Weinheim) Vol. 31; no. 16
Main Authors Fan, Jin‐Xuan, Peng, Meng‐Yun, Wang, He, Zheng, Hao‐Ran, Liu, Zong‐Lin, Li, Chu‐Xin, Wang, Xia‐Nan, Liu, Xin‐Hua, Cheng, Si‐Xue, Zhang, Xian‐Zheng
Format Journal Article
LanguageEnglish
Published Weinheim Wiley Subscription Services, Inc 19.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Synthetic biology based on bacteria has been displayed in antitumor therapy and shown good performance. In this study, an engineered bacterium Escherichia coli MG1655 is designed with NDH‐2 enzyme (respiratory chain enzyme II) overexpression (Ec‐pE), which can colonize in tumor regions and increase localized H2O2 generation. Following from this, magnetic Fe3O4 nanoparticles are covalently linked to bacteria to act as a catalyst for a Fenton‐like reaction, which converts H2O2 to toxic hydroxyl radicals (•OH) for tumor therapy. In this constructed bioreactor, the Fenton‐like reaction occurs with sustainably synthesized H2O2 produced by engineered bacteria, and severe tumor apoptosis is induced via the produced toxic •OH. These results show that this bioreactor can achieve effective tumor colonization, and realize a self‐supplied therapeutic Fenton‐like reaction without additional H2O2 provision. A Fenton‐like bioreactor based on bacteria is reported for tumor therapy without exogenous H2O2 provision. It is found that this bioreactor can achieve effective tumor colonization, and realize a self‐supplied therapeutic Fenton‐like reaction without additional H2O2 provision.
ISSN:0935-9648
1521-4095
DOI:10.1002/adma.201808278